Vertex Has 5 Billion-Plus Opportunity In Pain And Kidney Disease Programs, Analyst Upgrades Stock
| WSTYX Fund | USD 60.00 1.78 2.88% |
Slightly above 62% of Ivy Science's investor base is looking to short. The analysis of overall sentiment of trading Ivy Science And mutual fund suggests that many investors are alarmed at this time. Ivy Science's investing sentiment can be driven by a variety of factors including economic data, Ivy Science's earnings reports, geopolitical events, and overall market trends.
Ivy |
Jefferies has upgraded Vertex Pharmaceuticals Inc. , citing the companys robust cystic fibrosis base business and the additional upside from the new LNP mRNA therapy and triple pill regimens. The companys pipeline can potentially exceed expectations if the data is positive. The analyst views the riskreward balance as mostly neutral for 2024. The pain program stands out as a potential blockbuster, especially with the upcoming launch for acute pai
Read at finance.yahoo.com
 |
Ivy Science Fundamental Analysis
We analyze Ivy Science's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ivy Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ivy Science based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Ivy Science is currently under evaluation in number of employees among similar funds. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Ivy Science And Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ivy Science mutual fund to make a market-neutral strategy. Peer analysis of Ivy Science could also be used in its relative valuation, which is a method of valuing Ivy Science by comparing valuation metrics with similar companies.
Peers
Ivy Science Related Equities
| GBXIX | Nationwide Bond | 0.52 | ||||
| DLTNX | Doubleline Total | 0.23 | ||||
| JAFLX | Flexible Bond | 0.20 | ||||
| PRVBX | Versatile Bond | 0.11 | ||||
| CBOAX | Intermediate Bond | 0.08 | ||||
| TTRBX | Ambrus Core | 0.1 | ||||
| DLFNX | Doubleline Core | 0.21 | ||||
| GSNRX | Goldman Sachs | 0.22 |
Other Information on Investing in Ivy Mutual Fund
Ivy Science financial ratios help investors to determine whether Ivy Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ivy with respect to the benefits of owning Ivy Science security.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |